Bionomics Financial Statements From 2010 to 2024
| BNOEFDelisted Stock | USD 0.01 0.00 0.00% |
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
Bionomics |
Bionomics Limited Company Current Valuation Analysis
Bionomics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bionomics Current Valuation | 27.83 M |
Most of Bionomics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Bionomics Limited has a Current Valuation of 27.83 M. This is 99.81% lower than that of the Healthcare sector and 99.4% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.83% higher than that of the company.
Bionomics Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bionomics's current stock value. Our valuation model uses many indicators to compare Bionomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bionomics competition to find correlations between indicators driving Bionomics's intrinsic value. More Info.Bionomics Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bionomics' earnings, one of the primary drivers of an investment's value.About Bionomics Financial Statements
Bionomics stakeholders use historical fundamental indicators, such as Bionomics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Bionomics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bionomics' assets and liabilities are reflected in the revenues and expenses on Bionomics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bionomics Limited. Please read more on our technical analysis and fundamental analysis pages.
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |